ESR1 and obesity disorder: While both serine residues were phosphorylated under some circumstances, it was the S118 site that showed a consistent relationship with the tumor growth phenotype in the obese environment (i.e., FGF1 associated with ER S118 phosphorylation in cells from tumors that grow without estrogen supplementation in obesity).